EUVIMEDEUVIMED entdecken
Crossref

Comparative Analysis of Blood Pressure Control Among Heart Failure Patients on Standard Therapy with Sodium-Glucose Co-Transporter 2 Inhibitors Versus Standard Therapy Alone at Kenyatta National Hospital

Anthony K. Kamore, George A. Mugendi, David G. Nyamu

East and Central African Journal of Pharmaceutical Sciences · 2025 · 28 (1) · 16-26

DOI: 10.4314/ecajps.v28i1.3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift East and Central African Journal of Pharmaceutical Sciences, 2025. Verfasst von Anthony K. Kamore und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Recent changes to the management of heart failure have led to the introduction of Sodium-Glucose Co-transporter 2 Inhibitors (gliflozins) in therapy, with evidence showing better outcomes among patients treated with these agents. In Kenya, these agents are in use, but no studies have been carried out to examine their effects in this population. A retrospective cohort study was used to determine and compare the adequacy of blood pressure control among patients on and not on gliflozins. One hundred and two participant files were identified via simple random sampling and reviewed from January 2019 to December 2023. A data abstraction tool was used to collect information from sampled patient files. Analysis was performed in STATA version 17. Participants were equally distributed sex-wise, and the median age of those on gliflozins was 65 years (IQR 27), and that of those on standard therapy was 63 years (IQR 20). The overall median age was 63.5 years (IQR 23). Blood pressure control was achieved in both groups 24 hours after initiation of therapy and at discharge, with those on gliflozins having slightly better control at the 24-hour mark (OR =1.58, 95% CI:0.66 -3.79, p=0.302). At discharge, blood pressure control was marginally better in the gliflozin group (88.2%) compared to 84.3% in the standard therapy group (OR=1.40, 95%CI:0.45-4.35, p=0.566). Gliflozin–based therapy was associated with modestly better blood pressure control among heart failure patients compared to standard therapy, though differences were not statistically significant.

Zitieren

APA

Kamore, A. K., Mugendi, G. A., & Nyamu, D. G. (2025). Comparative Analysis of Blood Pressure Control Among Heart Failure Patients on Standard Therapy with Sodium-Glucose Co-Transporter 2 Inhibitors Versus Standard Therapy Alone at Kenyatta National Hospital. East and Central African Journal of Pharmaceutical Sciences, 28(1), 16-26. https://doi.org/10.4314/ecajps.v28i1.3

Vancouver

Kamore AK, Mugendi GA, Nyamu DG. Comparative Analysis of Blood Pressure Control Among Heart Failure Patients on Standard Therapy with Sodium-Glucose Co-Transporter 2 Inhibitors Versus Standard Therapy Alone at Kenyatta National Hospital. East and Central African Journal of Pharmaceutical Sciences. 2025;28(1):16-26. doi:10.4314/ecajps.v28i1.3

BibTeX
@article{Kamore2025,
  author = {Kamore, Anthony K. and Mugendi, George A. and Nyamu, David G.},
  title = {Comparative Analysis of Blood Pressure Control Among Heart Failure Patients on Standard Therapy with Sodium-Glucose Co-Transporter 2 Inhibitors Versus Standard Therapy Alone at Kenyatta National Hospital},
  journal = {East and Central African Journal of Pharmaceutical Sciences},
  year = {2025},
  volume = {28},
  number = {1},
  pages = {16--26},
  doi = {10.4314/ecajps.v28i1.3}
}
Kostenlos starten →